Skip to main content
PLOS Medicine logoLink to PLOS Medicine
. 2022 Feb 8;19(2):e1003889. doi: 10.1371/journal.pmed.1003889

Estimating impact of food choices on life expectancy: A modeling study

Lars T Fadnes 1,2,*, Jan-Magnus Økland 1,3, Øystein A Haaland 1,3,#, Kjell Arne Johansson 1,2,3,#
Editor: Luigi Fontana4
PMCID: PMC8824353  PMID: 35134067

Abstract

Background

Interpreting and utilizing the findings of nutritional research can be challenging to clinicians, policy makers, and even researchers. To make better decisions about diet, innovative methods that integrate best evidence are needed. We have developed a decision support model that predicts how dietary choices affect life expectancy (LE).

Methods and findings

Based on meta-analyses and data from the Global Burden of Disease study (2019), we used life table methodology to estimate how LE changes with sustained changes in the intake of fruits, vegetables, whole grains, refined grains, nuts, legumes, fish, eggs, milk/dairy, red meat, processed meat, and sugar-sweetened beverages. We present estimates (with 95% uncertainty intervals [95% UIs]) for an optimized diet and a feasibility approach diet. An optimal diet had substantially higher intake than a typical diet of whole grains, legumes, fish, fruits, vegetables, and included a handful of nuts, while reducing red and processed meats, sugar-sweetened beverages, and refined grains. A feasibility approach diet was a midpoint between an optimal and a typical Western diet. A sustained change from a typical Western diet to the optimal diet from age 20 years would increase LE by more than a decade for women from the United States (10.7 [95% UI 8.4 to 12.3] years) and men (13.0 [95% UI 9.4 to 14.3] years). The largest gains would be made by eating more legumes (females: 2.2 [95% UI 1.1 to 3.4]; males: 2.5 [95% UI 1.1 to 3.9]), whole grains (females: 2.0 [95% UI 1.3 to 2.7]; males: 2.3 [95% UI 1.6 to 3.0]), and nuts (females: 1.7 [95% UI 1.5 to 2.0]; males: 2.0 [95% UI 1.7 to 2.3]), and less red meat (females: 1.6 [95% UI 1.5 to 1.8]; males: 1.9 [95% UI 1.7 to 2.1]) and processed meat (females: 1.6 [95% UI 1.5 to 1.8]; males: 1.9 [95% UI 1.7 to 2.1]). Changing from a typical diet to the optimized diet at age 60 years would increase LE by 8.0 (95% UI 6.2 to 9.3) years for women and 8.8 (95% UI 6.8 to 10.0) years for men, and 80-year-olds would gain 3.4 years (95% UI females: 2.6 to 3.8/males: 2.7 to 3.9). Change from typical to feasibility approach diet would increase LE by 6.2 (95% UI 3.5 to 8.1) years for 20-year-old women from the United States and 7.3 (95% UI 4.7 to 9.5) years for men. Using NutriGrade, the overall quality of evidence was assessed as moderate. The methodology provides population estimates under given assumptions and is not meant as individualized forecasting, with study limitations that include uncertainty for time to achieve full effects, the effect of eggs, white meat, and oils, individual variation in protective and risk factors, uncertainties for future development of medical treatments; and changes in lifestyle.

Conclusions

A sustained dietary change may give substantial health gains for people of all ages both for optimized and feasible changes. Gains are predicted to be larger the earlier the dietary changes are initiated in life. The Food4HealthyLife calculator that we provide online could be useful for clinicians, policy makers, and laypeople to understand the health impact of dietary choices.


Lars Fadnes and co-workers estimate the possible benefits to life expectancy from adoption of more healthy diets.

Author summary

Why was this study done?

  • Food is fundamental for health, and globally dietary risk factors are estimated to cause 11 million deaths and 255 million disability-adjusted life years annually.

  • The Global Burden of Diseases, Injuries, and Risk Factors study (GBD) provides summary measures of population health that are relevant when comparing health systems but does not estimate the impact of alterations in food group composition and respective health benefits.

  • The EAT–Lancet commission did present a planetary diet, but it gives limited information on the health impact of other diets, and few people are able to adhere to strict health maximization approaches.

What did the researchers do and find?

  • Our modeling methodology using meta-analyses, data from the Global Burden of Disease study and life table methodology showed that life expectancy (LE) gains for prolonged changes from typical Western to optimizing diets could translate into more than a decade for young adults.

  • The largest gains would be made by eating more legumes, whole grains and nuts, and less red and processed meat.

  • For older people, the gains would be smaller but substantial. Even the feasibility approach diet indicates increased LE by 7% or more for both sexes across age groups.

What do these findings mean?

  • The online Food4HealthyLife calculator (https://food4healthylife.org/) enables the instant estimation of the effect on LE of a range of dietary changes.

  • Understanding the relative health potential of different food groups could enable people to make feasible and significant health gains.

  • The Food4HealthyLife calculator could be a useful tool for clinicians, policy makers, and laypeople to understand the health impact of dietary choices.

Introduction

Food is fundamental for health. Globally, dietary risk factors are estimated to cause 11 million deaths and 255 million disability-adjusted life years annually [1]. Still, navigating within the nutritional research field can be overwhelming to clinicians, policy makers, and even researchers. Since 2017, about 250,000 scientific articles on nutritionally related topics have been published (S1 Text). Fortunately, several recent meta-analyses have summarized the impact on the risk of premature deaths for various food groups, including fruits, vegetables, whole grains and refined grains, nuts and legumes, fish, eggs, milk/dairy, red and processed meats, and sugar-sweetened beverages [26].

The Global Burden of Disease study (GBD) provides summary measures of population health that are relevant when comparing health systems [7]. GBD includes population-level estimates for life years lost due to some dietary risk factors [8], but such aggregated health metrics have little relevance when making individual decisions. The EAT–Lancet commission did present a planetary diet that presented a diet balancing health and environmental perspectives [9], but it gives limited information on the health impact of other diets, and few people are able to adhere to strict health maximization approaches [10]. Although the planetary diet and GBD risk factor estimates indicate directions of changes in food intake that are useful, more comprehensive models estimating the impact of various dietary choices on lifetime health are needed.

To better understand the impact on health of dietary choices, we have developed methodology that integrates and presents current knowledge. The availability of such methodology is essential in order to make informed dietary choices at all levels from individuals to policy makers [11]. In this paper, we present new methodology that allows for the estimation of how different diets affect sex- and age-specific life expectancy (LE).

Methods

The LE at a certain age is the number of years an individual at that age is expected to live before they die given a set of age-specific mortality rates. We used mortality rates extracted from GBD 2019 (published in 2020) [12]. Johansson and colleagues presented a framework for measuring LE from disease onset for specific conditions [13]. We modified this approach by considering “change in diet” as a condition that may have both a positive and a negative health impact. Conceptually, our approach can be summed up as follows:

  1. Let LEage(D) be the age-specific LE with prolonged change to diet D.

  2. LEage(D) is calculated using standard age-specific lifetable methodology, where annual mortality rates are adjusted according to the selected diet (i.e., mortality rates after the age when the diet is changed are multiplied with the hazard rate corresponding to the change). The baseline diet yields LEage(D0).

  3. Life years gained (or lost) because of change from the baseline diet to diet D is now LEage(D)–LEage(D0).

A more detailed description of the methodology to estimate background LE is given in Johansson and colleagues’ paper [13].

Recent meta-analyses provided dose–response data on the impact of various food groups on mortality for the following food groups: whole grains, fruits, vegetables, nuts, legumes, fish, eggs, milk/dairy, refined grains, red meat, processed meat, and sugar-sweetened beverages [25]. To identify meta-analyses on these food groups, a search in PubMed dated 26 April 2021 was screened and data extracted from these (see search string in S2 Text). When several meta-analyses were available, we opted for the most comprehensive (usually the latest meta-analyses) with dose–response relationship data unless later less comprehensive meta-analyses argued well for excluding studies. For white meat, we did not have a complete dose–response curve, but a meta-analysis has suggested that the effect on mortality is neutral [14], which also was the case for small amounts of added oils [15]. Most of the studies were adjusted for intake of other food groups and factors such as smoking, exercise, body mass index, age, and sex. Each of the food groups were considered as individual protective or risk factors.

Diets vary between individuals and settings, but as the baseline in our model, we used a “typical Western diet” (TW) based on consumption data from the United States and Europe (S3 Text). The optimized diet (OD) values were set where dose–response data on consumption indicated no additional mortality gain in further increasing or decreasing intake (i.e., the impact on mortality plateaued). As a compromise between the TW and the optimal diet, we also considered a feasibility approach diet (FA), which was chosen as the midpoint for each food group between the typical diet and OD.

In each case, dietary intake was improved from the TW through feasible to optimal levels (rounded off):

  • Whole grains (fresh weight): TW 50 g, FA 137.5 g, and OD 225 g (e.g., 2 thin slices of rye bread and 1 small bowl of whole grain cereal, and some whole grain rice). For whole grains, 225 g of fresh weight corresponds to about 75 g dry weight, equivalent of 7 servings/day);

  • Vegetables: TW 250 g, FA 325 g, and OD 400 g (5 servings, e.g., 1 big tomato, 1 sweet pepper, mixed salad leaves, a half avocado, and a small bowl of vegetable soup);

  • Fruits: TW 200 g, 300 g, and OD 400 g (5 servings, e.g., 1 apple, banana, orange, kiwi, and a handful of berries);

  • Nuts: TW 0 g, FA 12.5 g, and OD 25 g (1 handful of nuts);

  • Legumes: TW 0 g, FA 100 g, and OD 200 g (e.g., 1 big cup of soaked beans/lentils/peas);

  • Fish: TW 50 g, FA 125 g, and OD 200 g (e.g., 1 big slice of herring);

  • Eggs: TW 50 g, FA 37.5 g, and OD 25 g (half an egg);

  • Milk/dairy: TW 300 g, FA 250 g, and OD 200 g (e.g., 1 cup of yoghurt);

  • Refined grains: TW 150 g, FA 100 g, OD 50 g (e.g., refined grains in bread if mixed whole/refined bread);

  • Red meat: TW 100 g, FA 50 g, and OD 0 g;

  • Processed meat: TW 50 g, FA 25 g, and OD 0 g;

  • White meat: TW 75 g, FA 62.5 g, and OD 50 g;

  • Sugar-sweetened beverages: TW 500 g, FA 250 g, and OD 0 g;

  • Added plant oils: TW 25 g, FA 25 g, and OD 25 g.

Other food groups were not considered. To avoid reporting estimates for insufficiently studied and unsustainable diet alternatives, the model does not report estimates if the total energy consumption for the diet input was below 4,000 kJ/day or above 16,000 kJ/day. Energy estimates per food group were obtained from a food content database [16]. The energy estimates were 8,085 kJ/day for TW, 7,850 kJ/day for FA, and 7,615 kJ/day for OD. The effect of energy restriction on longevity was not considered.

Health gains from diet changes are generally linked to reduction in cardiovascular disease, cancer, and diabetes mortality [25], all among the leading causes of mortality globally [17]. It has earlier been assumed that reversing the process of cardiovascular disease following reductions in major cardiovascular risk factors would require decades, but it has later been argued that cardiovascular disease mortality can change more quickly within a few years [18,19]. For cancers, the time perspective is likely to be longer. It has been indicated for associations between fruit and vegetable consumption and risk of lung cancer that associations for studies with more than 10 years of follow-up on fruits and vegetables are stronger than those with less than 10 years [20]. More evidence on the time perspective is available for risk factors such as tobacco, where meta-analyses for duration of smoking has indicated that associations between duration of tobacco smoking and risk of lung cancer is substantially higher with 50 years of smoking than 20 years of smoking [21]. To balance between the time perspectives related to both cardiovascular disease and cancer while weighting in the morbidity burden, we assumed that time to full effect was 10 years with a gradual, linear increase in effect (e.g., the effect was 20% of maximum after 2 years). We also conducted sensitivity analyses with 5 years, 30 years, and 50 years to full effect.

We used the following approach to calculate 95% uncertainty intervals (95% UIs) for the overall and food specific effect on LE of dietary changes: First, we extracted confidence intervals for the hazard rates for the proposed changes in intake of each food group from meta-analyses. Then, using a uniform distribution, we drew a number between the upper and lower 95% confidence interval for each food group and used this as input in the model. This procedure was repeated 200 times (with a fixed seed as starting point), and 95% uncertainty limits were selected as the 2.5 and 97.5 percentiles. Even though most meta-analyses adjusted for intake of other food groups, there is a possibility of different food groups presenting overlapping gains and thus overestimating the effects of each food group. Conversely, it is also possible that meta-analyses have overadjusted estimates so that the hazard ratios are closer to the null than the true effects. To take these effects into account, we conducted a new set of sensitivity analyses. In these analyses, we calculated alternative hazard ratios (HRa) based on HR0, the hazard ratio from the meta-analyses for a given change of intake for a given food group. Assuming first that HR0 < 1, we use the formula

HRa=HR0+1HR0*1m,

where m is a parameter taking on values from 0.5 to 1.5. If 0.5 < m < 1, the model becomes more conservative in the sense that the effect of dietary changes is reduced, whereas if 1 < m ≤ 1.5, the model becomes more “radical,” in that the effect is amplified. When HR0 > 1, we use HR0* = 1 / HR0 in (1) to get

HRa*=HR0*+1HR0*×1m,

and then finally HRa = 1 / HRa*.

In addition to the 95% UIs, we report sensitivity adjusted uncertainty intervals where the central estimate of the model is based on HR0 (i.e., m = 1), the lower interval is when m = 0.5 as and similarly the upper interval when m = 1.5.

Data on background mortality from 2019 for specific countries and regions were obtained from the freely available GBD cause of death database [12]. We extracted data for the United States, China, and Europe, as these are the regions from where most of the nutritional studies providing mortality estimates originate. Region-specific estimates on total mortality rates in 5-year age groups were also available from GBD. These were converted to single-year age-specific mortality rates in our model.

To assess the quality of evidence for each food group from the meta-analyses, we use NutriGrade, a version of GRADE adapted to nutritional studies [22]. Certainty of evidence is categorized as “very low” (0 to 3.99), “low” (4 to 5.99), “moderate” (6 to 7.99), or “high” (8 to 10). The quality of evidence was “high” for whole grains (NutriGrade score: 8), “moderate” for fish (7.75), processed meat (7.5), nuts (7), red meat (6.5), legumes (6), and dairy (6), “low” for vegetables (5.8), fruits (5.8), SSBs (5.5), and refined grains (5), and “very low” for eggs (3.8) and white meat (2). We further constructed an overall quality score by taking the mean of the NutriGrade scores for each of the food groups weighted by their absolute contribution to LE. The quality of the meta-analyses was assessed with the AMSTAR–2 tool [23]. The quality of the meta-analyses was rated as high for studies on all included meta-analyses [25,15], except for the meta-analysis on white meat that was rated as moderate [14].

We used the R package Shiny to create a web application (https://food4healthylife.org/) that enables the estimation of the effect of a range of dietary changes (S1 Fig). In the left food panel (i.e., the diet before change), the defaults are set to the “typical diet.” The right food panel represents diet after change. Clicking the “Optimal” or “Feasible” button, the right panel of sliders are adjusted to the 2 OD and FA diet patterns. In this paper, we present estimated gain in LE when changing from a typical diet to OD or FA for 20-, 40-, 60-, and 80-year-old adults from the United States, China, and Europe. Graphs including forest plots are calculated in Stata SE 17.0 (including the admetan package).

Only publicly available data sources have been used, and thus no ethical permission is required. We adhered to the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD; see S1 TRIPOD Checklist) [24].

Results

In this section, we will focus on the United States, but the results for China and Europe were generally very similar (can be found in S2S15 Figs). Table 1 and Fig 1 estimate the life expectancies at different ages associated with a typical Western diet, a feasibility approach diet, and an optimized diet. As seen, an increase in LE of up to 13.0 years (95% UI 9.4 to 14.3) is possible for male 20-year-olds from the United States by sustained dietary changes, and even for 80-year-olds, gains of 3.4 years (95% UI 2.7 to 3.9) are possible. Corresponding numbers for 20- and 80-year-old females are 10.7 years (95% UI 8.4 to 12.3) and 3.4 years (95% UI 2.6 to 3.8). Still, prolonged dietary changes at age 20 years would give about 48% higher gain in LE as changes starting from age 60 years, and 3 times the gains when compared with changes starting at age 80 years (Figs 2 and 3). Similar findings were seen for China and the United States. Changing from a typical diet to the feasibility approach diet would also give substantial gains for all age groups.

Table 1. LE for males and females at different ages from the United States, China, and Europe for different diets.

Gain in LE when changing from a typical Western diet to a feasibility approach or optimized diet is also indicated.

Region Typical Western Feasibility approach Optimized
Male Female Male Female Male Female
Age LE LE LE Gain LE Gain LE Gain LE Gain
United States 20 57.8 62.5 65.1 7.3 68.7 6.2 70.8 13.0 73.3 10.7
40 39.4 43.3 46.0 6.5 49.0 5.7 51.1 11.7 53.3 10.0
60 22.4 25.3 27.2 4.8 29.9 4.5 31.2 8.8 33.3 8.0
80 9.0 10.3 10.9 1.9 12.3 2.0 12.4 3.4 13.7 3.4
China 20 56.7 61.8 63.7 7.0 67.7 5.9 69.6 12.9 72.4 10.6
40 37.6 42.2 44.1 6.4 47.8 5.6 49.7 12.0 52.4 10.2
60 20.1 23.5 25.0 4.9 28.2 4.7 29.4 9.3 32.1 8.6
80 7.4 8.6 9.1 1.7 10.5 1.9 10.5 3.1 12.0 3.4
Europe 20 56.3 62.9 63.8 7.6 68.8 5.9 69.9 13.7 73.3 10.4
40 37.7 43.4 44.5 6.8 49.0 5.5 50.0 12.3 53.2 9.8
60 21.0 25.1 25.9 4.9 29.6 4.5 30.0 9.1 33.2 8.1
80 8.4 9.8 10.3 1.8 11.7 2.0 11.7 3.3 13.2 3.5

*For the optimal diet and feasibility approach diet, the following intakes were used: 225 g and 137.5 g whole grains (fresh weight), 400 g and 325 g vegetables, 400 g and/ 300 g fruits, 25 g and 12.5 g nuts, 200 g and/ 100 g legumes, 200 g and 100 g fish, 25 g and 37.5 g eggs, 200 g and 250 g milk/dairy, 50 g and 100 g refined grains, 0 g and 50 g red meat, 0 g and 25 g processed meat, 50 g and 62.5 g white meat, 0 g and 250 g sugar-sweetened beverages, and 25 g and 25 g added plant oils.

LE, life expectancy.

Fig 1. Expected life years gained for 20-year-old female adults (left forest plot) and males (right forest plot) from the United States who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams per day.

Fig 1

Estimates per food groups and total change in LE is presented with uncertainty intervals (UI). *The meta-evidence is high for whole grains; moderate for fish, nuts, legumes, processed and red meat, and sugar-sweetened beverages; and low for and very low for white meat. LE, life expectancy; 95% UI, 95% uncertainty interval.

Fig 2. Expected life years gained for 60-year-old female adults (left forest plot) and males (right forest plot) from the United States who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams per day.

Fig 2

Estimates per food groups and total change in LE is presented with uncertainty intervals (UI). *The meta-evidence is high for whole grains; moderate for fish, nuts, legumes, processed and red meat, and sugar-sweetened beverages; and low for and very low for white meat. LE, life expectancy; 95% UI, 95% uncertainty interval.

Fig 3. Expected increase in LE for optimizing different food groups with diet changes initiating from various ages between 20 and 80 years of age (left plot).

Fig 3

Right plot presents similar estimates with a feasible approach* diet (time to full effect: 10 years). *For the optimal diet and feasibility approach diet, the following intakes were used: 225 g and 137.5 g whole grains (fresh weight), 400 g and 325 g vegetables, 400 g and/ 300 g fruits, 25 g and 12.5 g nuts, 200 g and/ 100 g legumes, 200 g and 100 g fish, 25 g and 37.5 g eggs, 200 g and 250 g milk/dairy, 50 g and 100 g refined grains, 0 g and 50 g red meat, 0 g and 25 g processed meat, 50 g and 62.5 g white meat, 0 g and 250 g sugar-sweetened beverages, and 25 g and 25 g added plant oils. Note that lines for LE for red and processed meat changes are overlapping and similarly also for white meat and added oils. LE, life expectancy.

When changing from a typical Western to an optimized diet, the largest gains in LE could be made by eating more legumes, whole grains, and nuts, as well as eating less red meat and processed meat, with gradual reduction in effect with increasing age (Fig 2 and S2 Table). For a 20-year-old from the United States, LE would increase by more than 1 year for each of these food groups. Fruits and vegetables as well as fish had substantial positive impact, but the intake in a typical diet is closer to an optimal intake than for legumes, whole grains, and nuts.

S3 Table indicates that when increasing time to full effect from 10 years to 30 years, gains in LE were reduced by less than 1 year for 20-year-olds (i.e., by 4% to 7%), but the gains for 60-year-olds and 80-year-olds were reduced by 35% to 71%. Conversely, decreasing time to full effect from 10 years to 5 years (S16 Fig, S3 Table), health gains for 20-year-old females and males increased by 0.1 to 0.2 years (i.e., by 1% to 2%), whereas gains increased by 0.5 to 0.8 years for 60-year-olds (i.e., 6% to 9%) and 1.2 to 1.3 years for 80-year-olds (i.e., 35% to 38%) (S17 Fig).

The overall quality of evidence was moderate for the optimized diet (NutriGrade score: 6.5) and identical for the feasibility approach diet (NutriGrade score: 6.5).

Discussion

In this paper, we present a method for estimating the impact of food choices on LE. This method has been implemented in a tool that is freely available online—the Food4HealthyLife calculator. Our results indicate that for individuals with a typical Western diet, sustained dietary changes at any age may give substantial health benefits, although the gains are the largest if changes start early in life.

Eating more legumes, whole grains, and nuts, and eating less red meat and processed meats were estimated to be the most effective ways to increase LE for individuals with a typical diet. This reflects a combination of the health effect for each food group combined with the difference between typical and optimal intakes. Meta-analyses have also shown strong positive health effects from fruits, vegetables, and fish [2,5]. However, for these food groups, the typical intake was closer to optimal intake than for other food groups, particularly for vegetables. One could argue that for some food groups such as legumes, an optimal diet requires large intake and that such intakes might be unfeasible for many. Thus, we have also presented feasibility approach diet estimates that are closer to what we may realistically expect from diet changes of most people in most settings where ideals often are difficult to follow in practice. However, for most food groups, our estimates in the feasibility approach are within ranges that are common in cohort studies. There are also substantial individual variations in diet profile, which has impact on the potential health gain for each food group. As an example, some people have diets that are relatively similar to optimized diets and can expect less additional benefits from optimizing diets compared to individuals with a typical Western diet. Our food outcome calculation could take such variations at baseline into account by using different assumptions on nutrition starting points beyond what is presented here as default for a typical “Western diet.”

For several of the food groups, more than one meta-analysis is available. For red and processed meats, a more recent meta-analysis from 2019 than the one used in our estimates has been published [6]. However, this did not present dose–response data for red and processed meats separately, and the supplemental data for these groups combined indicated similar results as for the meta-analysis by Schwingshackl and colleagues. It is worthy to note that meta-analyses indicate worse outcomes on LE from processed meat than nonprocessed red meat when compared by weight, but if the consumption of unprocessed red meat consumption is double as high as for processed meat, the total effect is probably similar. For fish, whole grains, and legumes, more recent but smaller and less comprehensive meta-analyses were omitted from our data [2527]. These also provided similar effect estimates to the estimates we used. For some food groups such as dairy products, fruits, and vegetables, systematic reviews of meta-analyses were available and supported the selection of the data sources [28,29]. For added oils, there were mixed results depending on type of oil, where monounsaturated fatty acids such as olive oil have been reported to have beneficial effects [15,30,31]. As most added oils contain a combination of different types of fatty acids, the general trend for health impact of added oils is often neutral [15]. Many of the background studies were adjusted for other food groups. It can be argued that food groups are interrelated and thus not independent. Studies presenting outcome measures with and without adjustment for other food groups have generally indicated minimal changes in the outcome measures [3234]. To account for this possibility, we added sensitivity analyses model adjustment.

Our method has several strengths. First, our food impact estimates are from the most comprehensive and recent meta-analyses presenting dose–response data on diet patterns and mortality. We also have developed methodology that integrates different aspects such as time to full effects and potentially some degree of overlapping with sensitivity analyses and uncertainty intervals.

Our method also has several limitations. Meta-analyses present associations and some caution must be used when interpreting these. Still, meta-analyses are in many cases the best available evidence available as trials on diets could be challenging and, in several cases, could be unethical. Thus, emphasized several sensitivity analyses. For some food groups, meta-analyses presenting dose–response data were not available, which yield more uncertainty in model output.

The meta-analyses used in these data had high quality [23], while the meta-evidence ranged from very low (eggs and white meat) to high (whole grains) with most in the moderate quality category [22]. The overall meta-evidence was estimated as moderate for the optimal and feasibility approach diets. Still, the quality of the evidence for diet changes mostly involving eggs and white meat would be lower than when diet changes are dominated by whole grains, fish, processed meat, and nuts. This is reported in the tool for transparency. For added oils, it is likely that olive oils that are rich in monounsaturated fatty acids have beneficial effects and are probably superior to several other added oils [15,30,31]. However, we did not have sufficient data to present different oils separately.

GBD provides background epidemiological data for the populations we have presented but involves a combination of background data and modeling. We have no information on the impact on past morbidity experienced due to disease, and this was therefore not included in the model, although different health profiles may be associated with different impact of food choices. Thus, our estimates are based on population distributions of health indicators and do not account for differences in risk factors nor genetic vulnerability. The time perspective of diet change adds another layer of uncertainty. The duration of changes in the studies varies, and it is likely that short-term changes yield weaker effects than those presented in this article. We assumed 10 years to achieve full effects while conducting sensitivity analyses for both 5, 30, and 50 years. Still, progress in development of medical treatments and continuous changes in lifestyle can affect the impact of diet on LE and thus add uncertainty to our estimates [35]. Thus, the methodology is not meant as individualized forecasting of life years gained, but rather population estimates under certain assumptions.

Even though the diet approaches were relatively similar in energy, energy differences may have played a role in the relationships presented, and meta-analyses indicate that patterns in line with the optimal diet are likely to reduce the risk of obesity/overweight [36]. From the literature, we also know that one’s diet has a large impact on health-related quality of life [24,3639]. Although we do not model nonfatal effects, LE is correlated with healthy life years. Most of the background data are adjusted for factors such as smoking, exercise, age, and sex. However, some residual confounding may still affect the estimates. Further, we have not considered any long-term health consequences that are due to sustained excessive intake of food with high levels of toxins, such as dioxins and polychlorinated biphenyls, which are relevant for some types of fish and sea foods [40,41]. This is more likely to overestimate than underestimate effect sizes. There is also a risk of overadjustment as some of the studies included in meta-analyses adjusted for potential intermediate factors. This may contribute to underestimating the full impact on dietary changes on health. Model development often have iterative improvements that will gradually give more precise estimates; however, the main messages are likely to be robust. Our sensitivity analyses indicate how the estimated changes in LE due to dietary changes vary if the true effects are over- or underestimated. Even the most conservative approaches indicate strong effects.

In conclusion, sustained change from a typical to an optimized diet from early age could translate into an increase in LE of more than 10 years. Gains are reduced substantially with delayed initiation of changes, particularly when approaching the age of 80 years. An increase in the intake of legumes, whole grains, and nuts, and a reduction in the intake of red meat and processed meats, contributed most to these gains. Fruits and vegetables also have a positive health impact, but for these food groups, the intake in a typical Western diet is closer to the optimal intake than for the other food groups. The Food4HealthyLife calculator could be a useful tool for both clinicians, policy makers, and laypeople to understand impact of various food choices.

Supporting information

S1 Text. Medline/PubMed search to estimate number of nutritional articles per year.

(PDF)

S2 Text. String used in PubMed to identify meta-analyses for setting hazard ratios.

(PDF)

S3 Text. Estimated intake of various food groups in the United States and Norway.

(PDF)

S1 Table. Hazard ratios (with uncertainty intervals) for various food groups with uncertainty limits (orange/red labels).

(PDF)

S2 Table. Increase in LE for each food group change for 20- and 60-year-old female and male adults from the United States, who change from a TW to OD or FA.

FA, feasibility approach diet; LE, life expectancy; OD, optimized diet; TW, typical Western diet.

(PDF)

S3 Table. Absolute and relative change in LE with delay to full effects of 10 (default), 5, 30, and 50 years for 20-, 40-, 60-, and 80-year-old females and males from the United States.

LE, life expectancy.

(PDF)

S1 Fig. Example of calculator input and output.

(PDF)

S2 Fig. Expected life years gained for 20-year-old female adults from China who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams.

(PNG)

S3 Fig. Expected life years gained for 20-year-old male adults from China who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S4 Fig. Expected life years gained for 20-year-old female adults from Europe who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S5 Fig. Expected life years gained for 20-year-old male adults from Europe who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S6 Fig. Expected life years gained for 20-year-old female adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S7 Fig. Expected life years gained for 20-year-old male adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S8 Fig. Expected life years gained for 40-year-old female adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S9 Fig. Expected life years gained for 40-year-old male adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S10 Fig. Expected life years gained for 60-year-old female adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S11 Fig. Expected life years gained for 60-year-old male adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S12 Fig. Expected life years gained for 80-year-old female adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S13 Fig. Expected life years gained for 80-year-old male adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

(PNG)

S14 Fig. Expected life years gained for 20-, 40-, 60-, and 80-year-old male and female adults from the US, China, and EU, who change from a typical Western diet to an optimized* (labeled “Optimal”) or a feasibility approach diet* (labeled “Feasible”).

Estimates for change in LE is presented with 95% UIs. *For the optimal diet and feasibility approach diet, the following intakes were used: 225/137.5 g whole grains (fresh weight), 400/325 g vegetables, 400/300 g fruits, 25/12.5 g nuts, 200/100 g legumes, 200/125 g fish, 25/37.5 g eggs, 200/250 g milk/dairy, 50/100 g refined grains, 0/50 g red meat, 0/25 g processed meat, 50/62.5 g white meat, 0/250 g sugar-sweetened beverages, and 25/25 g added plant oils. **F20 indicates 20-year-old females, and M60 indicates 60-year-old males. Uncertainty intervals for some food groups have rounding differences compared to corresponding S2 Table due to symmetrical adjustment in the admetan package in Stata. EU, Europe; LE, life expectancy; US, United States; 95% UI, 95% uncertainty interval.

(PNG)

S15 Fig. Expected life years gained for 20-, 40-, 60-, and 80-year-old male and female adults from the US, China, and EU, who change from a typical Western diet to an optimized* (labeled “Optimal”) or a feasibility approach diet* (labeled “Feasible”).

Estimates for change in LE is presented with sensitivity adjusted uncertainty intervals using lower interval as model adjustment of 0.5 and upper interval as model adjustment of 1.5. *For the optimal diet and feasibility approach diet, the following intakes were used: 225/137.5 g whole grains (fresh weight), 400/325 g vegetables, 400/300 g fruits, 25/12.5 g nuts, 200/100 g legumes, 200/125 g fish, 25/37.5 g eggs, 200/250 g milk/dairy, 50/100 g refined grains, 0/50 g red meat, 0/25 g processed meat, 50/62.5 g white meat, 0/250 g sugar-sweetened beverages, and 25/25 g added plant oils. **F20 indicates 20-year-old females, and M60 indicates 60-year-old males. Uncertainty intervals for some food groups have rounding differences compared to corresponding S2 Table due to symmetrical adjustment in the admetan package in Stata. EU, Europe; LE, life expectancy; US, United States.

(PNG)

S16 Fig. Expected increase in LE for optimizing different food groups with diet changes initiating from various ages between 20 and 80 years of age (time to full effect: 5 years).

*For the optimal diet and feasibility approach diet, the following intakes were used: 225 g and 137.5 g whole grains (fresh weight), 400 g and 325 g vegetables, 400 g and/ 300 g fruits, 25 g and 12.5 g nuts, 200 g and/ 100 g legumes, 200 g and 100 g fish, 25 g and 37.5 g eggs, 200 g and 250 g milk/dairy, 50 g and 100 g refined grains, 0 g and 50 g red meat, 0 g and 25 g processed meat, 50 g and 62.5 g white meat, 0 g and 250 g sugar-sweetened beverages, and 25 g and 25 g added plant oils. LE, life expectancy.

(PDF)

S17 Fig. Expected increase in LE for optimizing different food groups with diet changes initiating from various ages between 20 and 80 years of age (time to full effect: 30 years).

*For the optimal diet and feasibility approach diet, the following intakes were used: 225 g and 137.5 g whole grains (fresh weight), 400 g and 325 g vegetables, 400 g and/ 300 g fruits, 25 g and 12.5 g nuts, 200 g and/ 100 g legumes, 200 g and 100 g fish, 25 g and 37.5 g eggs, 200 g and 250 g milk/dairy, 50 g and 100 g refined grains, 0 g and 50 g red meat, 0 g and 25 g processed meat, 50 g and 62.5 g white meat, 0 g and 250 g sugar-sweetened beverages, and 25 g and 25 g added plant oils. LE, life expectancy.

(PDF)

S1 TRIPOD Checklist. Checklist for prediction model development.

(PDF)

Acknowledgments

Thanks to Arngeir Berge for assistance with images.

Abbreviations

95% UI

95% uncertainty interval

FA

feasibility approach diet

GBD

Global Burden of Disease study

HRa

alternative hazard ratio

LE

life expectancy

OD

optimized diet

TW

typical Western diet

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393(10184):1958–72. Epub 2019 Apr 8. doi: 10.1016/S0140-6736(19)30041-8 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Aune D, Giovannucci E, Boffetta P, Fadnes LT, Keum N, Norat T, et al. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all–cause mortality–a systematic review and dose–response meta–analysis of prospective studies. Int J Epidemiol. 2017;46(3):1029–56. Epub 2017 Mar 25. doi: 10.1093/ije/dyw319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, et al.Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose–response meta–analysis of prospective studies. BMJ. 2016;353:i2716. Epub 2016 Jun 16. doi: 10.1136/bmj.i2716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, et al. Nut consumption and risk of cardiovascular disease, total cancer, all–cause and cause–specific mortality: a systematic review and dose–response meta–analysis of prospective studies. BMC Med. 2016;14(1):207. Epub 2016 Dec 6. doi: 10.1186/s12916-016-0730-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Schwingshackl L, Schwedhelm C, Hoffmann G, Lampousi AM, Knüppel S, Iqbal K, et al. Food groups and risk of all–cause mortality: a systematic review and meta–analysis of prospective studies. Am J Clin Nutr. 2017;105(6):1462–73. Epub 2017 Apr 28. doi: 10.3945/ajcn.117.153148 . [DOI] [PubMed] [Google Scholar]
  • 6.Zeraatkar D, Han MA, Guyatt GH, Vernooij RWM, El Dib R, Cheung K, et al. Red and Processed Meat Consumption and Risk for All–Cause Mortality and Cardiometabolic Outcomes: A Systematic Review and Meta–analysis of Cohort Studies. Ann Intern Med. 2019. Epub 2019 Oct 1. doi: 10.7326/M19-0655 . [DOI] [PubMed] [Google Scholar]
  • 7.GBD Causes of Death Collaborators. Global, regional, and national age–sex–specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88. Epub 2018 Nov 30. doi: 10.1016/S0140-6736(18)32203-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Institute for Health Metrics and Evaluation and collaborators. Global Burden of Disease study (2017, 2016, 2015, 2013 and 2010). Lancet. 2018, 2017, 2016, 2014, 2012.
  • 9.Willett W, Rockstrom J, Loken B, Springmann M, Lang T, Vermeulen S, et al. Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems. Lancet. 2019;393(10170):447–92. Epub 2019 Jan 21. doi: 10.1016/S0140-6736(18)31788-4 . [DOI] [PubMed] [Google Scholar]
  • 10.Cookson R, Mirelman AJ, Griffin S, Asaria M, Dawkins B, Norheim OF, et al. Using Cost–Effectiveness Analysis to Address Health Equity Concerns. Value Health. 2017;20(2):206–12. Epub 2017 Feb 27. doi: 10.1016/j.jval.2016.11.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Greenberg D, Neumann PJ. Cost–Effectiveness Analysis Expands its Reach Worldwide. Value Health Reg Issues. 2016;10:101–2. doi: 10.1016/j.vhri.2016.10.001 . [DOI] [PubMed] [Google Scholar]
  • 12.The Institute for Health Metrics and Evaluation (IHME). The Global Health Data Exchange (GHDx) Institute for Health Metrics and Evaluation, University of Washington. http://ghdx.healthdata.org/gbd-results-tool.
  • 13.Johansson KA, Okland JM, Skaftun EK, Bukhman G, Norheim OF, Coates MM, et al. Estimating Health Adjusted Age at Death (HAAD). PLoS ONE. 2020;15(7). ARTN e0235955 doi: 10.1371/journal.pone.0235955 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Abete I, Romaguera D, Vieira AR, Lopez de Munain A, Norat T. Association between total, processed, red and white meat consumption and all–cause, CVD and IHD mortality: a meta–analysis of cohort studies. Br J Nutr. 2014;112(5):762–75. doi: 10.1017/S000711451400124X . [DOI] [PubMed] [Google Scholar]
  • 15.Abdelhamid AS, Martin N, Bridges C, Brainard JS, Wang X, Brown TJ, et al. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;7:CD012345. Epub 2018 Jul 19. doi: 10.1002/14651858.CD012345.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mattilsynet. Matvaretabellen. https://www.matvaretabellen.no/?language=en.
  • 17.GBD 2017 Causes of Death Collaborators. Global, regional, and national age–sex–specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88. Epub 2018 Nov 30. doi: 10.1016/S0140-6736(18)32203-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Capewell S, O’Flaherty M. Can dietary changes rapidly decrease cardiovascular mortality rates? Eur Heart J. 2011;32(10):1187–9. Epub 2011 Mar 4. doi: 10.1093/eurheartj/ehr049 . [DOI] [PubMed] [Google Scholar]
  • 19.Capewell S O’Flaherty M. Rapid mortality falls after risk–factor changes in populations. Lancet. 2011;378(9793):752–3. Epub 2011 Mar 19. doi: 10.1016/S0140-6736(10)62302-1 . [DOI] [PubMed] [Google Scholar]
  • 20.Wang Y, Li F, Wang Z, Qiu T, Shen Y, Wang M. Fruit and vegetable consumption and risk of lung cancer: a dose–response meta–analysis of prospective cohort studies. Lung Cancer. 2015;88(2):124–30. Epub 2015 Mar 10. doi: 10.1016/j.lungcan.2015.02.015 . [DOI] [PubMed] [Google Scholar]
  • 21.Lee PN, Forey BA, Coombs KJ. Systematic review with meta–analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer. 2012;12:385. Epub 2012 Sep 5. doi: 10.1186/1471-2407-12-385 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Schwingshackl L, Knuppel S, Schwedhelm C, Hoffmann G, Missbach B, Stelmach–Mardas M, et al. Perspective: NutriGrade: A Scoring System to Assess and Judge the Meta–Evidence of Randomized Controlled Trials and Cohort Studies in Nutrition Research. Adv Nutr. 2016;7(6):994–1004. doi: 10.3945/an.116.013052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non–randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. Epub 2017 Sep 25. doi: 10.1136/bmj.j4008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015;13:1. Epub 2015 Jan 8. doi: 10.1186/s12916-014-0241-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wan Y, Zheng J, Wang F, Li D. Fish, long chain omega–3 polyunsaturated fatty acids consumption, and risk of all–cause mortality: a systematic review and dose–response meta–analysis from 23 independent prospective cohort studies. Asia Pac J Clin Nutr. 2017;26(5):939–56. Epub 2017 Aug 15. doi: 10.6133/apjcn.072017.01 . [DOI] [PubMed] [Google Scholar]
  • 26.Zhang B, Zhao Q, Guo W, Bao W, Wang X. Association of whole grain intake with all–cause, cardiovascular, and cancer mortality: a systematic review and dose–response meta–analysis from prospective cohort studies. Eur J Clin Nutr. 2018;72(1):57–65. Epub 2017/11/02. doi: 10.1038/ejcn.2017.149 . [DOI] [PubMed] [Google Scholar]
  • 27.Li H, Li J, Shen Y, Wang J, Zhou D. Legume Consumption and All–Cause and Cardiovascular Disease Mortality. Biomed Res Int. 2017;2017:8450618. Epub 2017 Dec 13. doi: 10.1155/2017/8450618 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yip CSC, Chan W, Fielding R. The Associations of Fruit and Vegetable Intakes with Burden of Diseases: A Systematic Review of Meta–Analyses. J Acad Nutr Diet. 2019;119(3):464–81. Epub 2019 Jan 15. doi: 10.1016/j.jand.2018.11.007 . [DOI] [PubMed] [Google Scholar]
  • 29.Cavero–Redondo I, Alvarez–Bueno C, Sotos–Prieto M, Gil A, Martinez–Vizcaino V, Ruiz JR. Milk and Dairy Product Consumption and Risk of Mortality: An Overview of Systematic Reviews and Meta–Analyses. Adv Nutr. 2019;10(suppl_2):S97–S104. Epub 2019 May 16. doi: 10.1093/advances/nmy128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review and meta–analysis of cohort studies. Lipids Health Dis. 2014;13:154. Epub 2014 Oct 3. doi: 10.1186/1476-511X-13-154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Estruch R, Ros E, Salas–Salvado J, Covas MI, Corella D, Aros F, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra–Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34. Epub 2018 Jun 14. doi: 10.1056/NEJMoa1800389 . [DOI] [PubMed] [Google Scholar]
  • 32.Roswall N, Sandin S, Lof M, Skeie G, Olsen A, Adami HO, et al. Adherence to the healthy Nordic food index and total and cause–specific mortality among Swedish women. Eur J Epidemiol. 2015;30(6):509–17. Epub 2015 Mar 19. doi: 10.1007/s10654-015-0021-x . [DOI] [PubMed] [Google Scholar]
  • 33.Vormund K, Braun J, Rohrmann S, Bopp M, Ballmer P, Faeh D. Mediterranean diet and mortality in Switzerland: an alpine paradox? Eur J Nutr. 2015;54(1):139–48. Epub 2014 Apr 9. doi: 10.1007/s00394-014-0695-y . [DOI] [PubMed] [Google Scholar]
  • 34.Prinelli F, Yannakoulia M, Anastasiou CA, Adorni F, Di Santo SG, Musicco M, et al. Mediterranean diet and other lifestyle factors in relation to 20–year all–cause mortality: a cohort study in an Italian population. Br J Nutr. 2015;113(6):1003–11. Epub 2015 Mar 10. doi: 10.1017/S0007114515000318 . [DOI] [PubMed] [Google Scholar]
  • 35.Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all–cause and cause–specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90. Epub 2018 Oct 21. doi: 10.1016/S0140-6736(18)31694-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Schlesinger S, Neuenschwander M, Schwedhelm C, Hoffmann G, Bechthold A, Boeing H, et al. Food Groups and Risk of Overweight, Obesity, and Weight Gain: A Systematic Review and Dose–Response Meta–Analysis of Prospective Studies. Adv Nutr. 2019;10(2):205–18. doi: 10.1093/advances/nmy092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Schwingshackl L, Hoffmann G, Iqbal K, Schwedhelm C, Boeing H. Food groups and intermediate disease markers: a systematic review and network meta–analysis of randomized trials. Am J Clin Nutr. 2018;108(3):576–86. doi: 10.1093/ajcn/nqy151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Schwingshackl L, Hoffmann G, Lampousi AM, Knuppel S, Iqbal K, Schwedhelm C, et al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta–analysis of prospective studies. Eur J Epidemiol. 2017;32(5):363–75. doi: 10.1007/s10654-017-0246-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Schwingshackl L, Schwedhelm C, Hoffmann G, Knuppel S, Preterre AL, Iqbal K, et al. Food groups and risk of colorectal cancer. Int J Cancer. 2018;142(9):1748–58. doi: 10.1002/ijc.31198 [DOI] [PubMed] [Google Scholar]
  • 40.Malisch R, Kotz A. Dioxins and PCBs in feed and food––review from European perspective. Sci Total Environ. 2014;491–492:2–10. Epub 2014 May 9. doi: 10.1016/j.scitotenv.2014.03.022 . [DOI] [PubMed] [Google Scholar]
  • 41.Faroon O, Jones D, de Rosa C. Effects of polychlorinated biphenyls on the nervous system. Toxicol Ind Health. 2000;16(7–8):305–33. Epub 2001 Nov 6. doi: 10.1177/074823370001600708 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Richard Turner

21 Sep 2021

Dear Dr Fadnes,

Thank you for submitting your manuscript entitled "Food for a Healthy Life: Estimating Impact of Food Choices on Life Expectancy" for consideration by PLOS Medicine.

Your manuscript has now been evaluated by the PLOS Medicine editorial staff and I am writing to let you know that we would like to send your submission out for external assessment.

However, we first need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by Sep 23 2021 11:59PM.

Login to Editorial Manager here: https://www.editorialmanager.com/pmedicine

Once your full submission is complete, your paper will undergo a series of checks in preparation for full assessment.

Feel free to email us at plosmedicine@plos.org if you have any queries relating to your submission.

Kind regards,

Richard Turner, PhD

Senior Editor, PLOS Medicine

rturner@plos.org

Decision Letter 1

Richard Turner

20 Oct 2021

Dear Dr. Fadnes,

Thank you very much for submitting your manuscript "Food for a Healthy Life: Estimating Impact of Food Choices on Life Expectancy" (PMEDICINE-D-21-04011R1) for consideration at PLOS Medicine.

Your paper was discussed among the editors and sent to independent reviewers, including a statistical reviewer. The reviews are appended at the bottom of this email and any accompanying reviewer attachments can be seen via the link below:

[LINK]

In light of these reviews, we will not be able to accept the manuscript for publication in the journal in its current form, but we would like to invite you to submit a revised version that addresses the reviewers' and editors' comments fully. You will appreciate that we cannot make a decision about publication until we have seen the revised manuscript and your response, and we expect to seek re-review by one or more of the reviewers.

In revising the manuscript for further consideration, your revisions should address the specific points made by each reviewer and the editors. Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. In your rebuttal letter you should indicate your response to the reviewers' and editors' comments, the changes you have made in the manuscript, and include either an excerpt of the revised text or the location (eg: page and line number) where each change can be found. Please submit a clean version of the paper as the main article file; a version with changes marked should be uploaded as a marked up manuscript.

In addition, we request that you upload any figures associated with your paper as individual TIF or EPS files with 300dpi resolution at resubmission; please read our figure guidelines for more information on our requirements: http://journals.plos.org/plosmedicine/s/figures. While revising your submission, please upload your figure files to the PACE digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at PLOSMedicine@plos.org.

We hope to receive your revised manuscript by Nov 10 2021 11:59PM. Please email us (plosmedicine@plos.org) if you have any questions or concerns.

***Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.***

We ask every co-author listed on the manuscript to fill in a contributing author statement, making sure to declare all competing interests. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. If new competing interests are declared later in the revision process, this may also hold up the submission. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT. You can see our competing interests policy here: http://journals.plos.org/plosmedicine/s/competing-interests.

Please use the following link to submit the revised manuscript:

https://www.editorialmanager.com/pmedicine/

Your article can be found in the "Submissions Needing Revision" folder.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please ensure that the paper adheres to the PLOS Data Availability Policy (see http://journals.plos.org/plosmedicine/s/data-availability), which requires that all data underlying the study's findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by "data not shown" or "unpublished results." For such statements, authors must provide supporting data or cite public sources that include it.

Please let me know if you have any questions, and we look forward to receiving your revised manuscript.

Sincerely,

Richard Turner, PhD

Senior editor, PLOS Medicine

rturner@plos.org

-----------------------------------------------------------

Requests from the editors:

Please adapt the title to better match journal style, including a study descriptor, and we suggest: "Estimating impact of food choices on life expectancy: A modeling study".

In the abstract, please add a new final sentence to the "Methods and findings" subsection, which should begin "Study limitations include ..." or similar and should quote 2-3 of the study's main limitations.

In the abstract and main text, please state the year of the GBD data used.

We suspect that the statement "The quality of evidence was moderate (NutriGrade)" (abstract) will need a few words of explanation.

Please move the author summary after the abstract.

Please adapt the author summary so that the third subsection is titled "What do these findings mean?"; we recommend about three points in each of the three subsections.

Noting "... and even lay people" in the author summary, we suggest removing the word "even", which could appear slightly patronising.

Throughout the text, please move reference call-outs before punctuation (e.g., "... annually [1].").

Please remove information on funding, competing interests and data sharing from the end of the main text. In the event of publication, this information will appear in the article metadata, via entries in the submission form.

Please move the information on ethics approvals to the Methods section (main text).

In the reference list, please remove the information on competing interests from reference 18 and any other relevant references.

Thank you for including the completed TRIPOD checklist. Please rename the attachment "S1_TRIPOD_Checklist" or similar, and refer to it by this label in the Methods section (main text).

Please adapt the checklist so that individual items are referred to by section (e.g., "Methods") and paragraph number, not by line or page numbers as these generally change in the event of publication.

Comments from the reviewers:

*** Reviewer #1:

Estimating Impact of Food Choices on Life Expectancy

Fadnes at al. PLoS Med PMEDICINE-D-21-04011R1

This is a very interesting study, generally well written, with potentially important policy messages.

The life-table modelling approach used effect sizes from GBD meta-analyses and data to estimate life expectancy (LE) changes with moderate (FA) or large (OD) sustained changes in the intake of fruits, vegetables, whole grains, refined grains, nuts, legumes, fish, eggs, milk/dairy, red meat, processed meat, and sugar-sweetened beverages.

The paper presents estimated gain in life expectancy when changing from a typical diet to OD or FA for 20-, 40-60- and 80-year-old adults from Europe, China, and the United States.

Changing from a typical western diet to the optimal diet could increase LE by more than a decade for European men & women, if starting at 20, but with still useful gains even if starting at a later age.

Changing to a more feasible but less radicle diet might generate about half the benefit.

The underlying modelling idea is ambitious, and doubly impressive given the apparent lack of external funding.

At present, the analysis is handicapped by a couple of major limitations, as detailed below.

However, these should be fairly easy to sort out.

Furthermore, I think the manuscript presentation could itself be made even better in one or two places, as detailed below

ABSTRACT

Generally clear.

However, we need a brief message regarding how large a change would be required to move to either the feasible approach (FA) or optimal diets (OD).

It would be helpful even if you just said " the OD would typically involve doubling the intake of healthy foods, and halving the intake of unhealthy foods" .

(And that might be reasonably close to many of the actual detailed values chosen).

INTRODUCTION

Generally fine,

and commendably brief.

METHODS

The Life Table methodology is uncontroversial.

The key issues with such models tend to be the choice of effect sizes, lag times and sensitivity analyses.

But firstly, a simple presentational issue.

Page 5, para beginning "Diets vary between individuals and settings.."

This para is very difficult to read.

I would suggest a modest revision to juxtapose the three levels for each food group, thus:

" The optimized diet (OD) values were set where dose-response data on consumption indicated no additional mortality gain in further increasing or decreasing intake (i.e., the impact on mortality plateaued). As a compromise between the typical diet and the optimal diet, we also considered a feasibility-approach diet (FA), which was chosen as the mid-point for each food group between the typical diet and OD. "

Then:

" In each case, dietary intake was improved from the typical western diet through feasible to optimal levels -

whole grains (fresh weight): 50g, FD 125g and OD 225g

vegetables, 250g, 325g and 400g , respectively"

and so on.

Thus, at a glance, readers can then see how modest or radical were each of the required changes.

Page 5.

The extensive sensitivity analyses are to be commended.

Likewise using NutriGrade to assess the quality of the published evidence

The https://food4healthylife.org/ website is ambitious, but impressive.

The para on time lags is just plain wrong.

The authors currently state:

"As health gains from diet changes are generally linked to reduction in cardiovascular disease

and cancers,[2-5] it is likely that effects of changes will increase gradually over a few

decades. We therefore assumed delayed onset of benefits and that time to full effect were 30

years from diet change with a gradual, linear increase in effect (e.g., the effect was 20% after

6 years), and conducted sensitivity analyses with 10 years and 50 years delays until full effect."

In fact, many studies have reported event and mortality changes starting within months of a change in the population, and becoming substantial within a few years (not decades).

That needs to be factored in, and the modelling estimates then need to be repeated.

The good news is that the estimated benefits could happen much sooner (see my comments below on Page 7, Para 2).

The current para on lag-times therefore needs to be deleted, and a more up-to-date summary inserted, referencing the relevant literature.

That might include, for instance, mention Lancet, 2011; 378: 752-753, and European Heart Journal (2011) 32, 1187-1189, Can dietary changes rapidly decrease cardiovascular mortality rates? doi:10.1093/eurheartj/ehr049. The subsequent publications which cite these early scoping reviews might also be worth a quick look.

I would consider that this minor revision of the model would be essential before being accepted for publication.

RESULTS

Generally good.

From a publishing tactical point of view, you might enjoy MUCH higher citation rates if you detail the USA results in the Results text,

and place the European & Chinese results in the Appendix.

In terms of face validity, one might have expected bigger benefits from increasing veg compared with fruit,

And smaller benefits from reducing red meat, compared with processed meats.

Page 7 Para 2 currently states

"Conversely, decreasing time-to-full-effect from 30 years to 10 years, health gains for 20-yearold

females and males increased by almost a year (i.e., by 3-7%), whereas gains increased by

three to four years for 60-year-olds (i.e., 53-78%) and more than two years for 80-year-olds

(i.e., 250-267%)."

I suspect that these values may be close to the ones you obtain after you revise the lag-times in your model, as advised above.

DISCUSSION

Generally good.

Making the Food4HealthyLife calculator freely available online is commendable.

However, the language needs attention.

These outputs are estimates, based on an early version of a new model, using imperfect data, and awaiting replication.

They do not "show" anything. The appropriate language should therefore be more cautious, using words such as "suggest", "indicate" etc.

The definitive language therefore needs to be toned down. Eg "Our results show…."

The Concluding paragraph is thus much better, mainly saying "could".

Page 8. The para begging " Our method has several strengths and limitations " is messy.

It would be best to split the messages into a short para on strengths, and a longer one on Limitations, adding the further limitations that I and the other referees have identified.

None are catastrophic, but it is tactically sensible to acknowledge each one here. That will pre-empt embarrassing letters to the journal, or more public criticisms.

LIMITATIONS

Please add the further limitations that I and the other referees have identified.

These include:

You need to add a sentence or two critiquing GBD. While stupendous in scale, it has many imperfections. A five minute web-search will identify a few.

The analysis appears to downplay olive oil, which proved very powerful in the large PrediMED RCT.

The authors could easily test a bigger effect in a quick sensitivity analysis.

Likewise, the OD for nuts should probably be 40g, rather than 25g, (Estruch NEJM 2028)

This model is at an early stage of development.

Iterative improvements are likely to mean that the precise numerical outputs are therefore change; however, the main messages are likely to prove robust.

FIGURES

Fig 1 is good

Fig 2 is visually outstanding, while demonstrating some complex effects in a very accessible way.

*** Reviewer #2:

That nutrition plays a role in the pathogenesis of many chronic diseases is well known. It is also known that manipulation of specific molecular pathways by nutritional (dietary restriction) and exercise training can impact aging and life expectancy. However, it seems that energy intake/balance (and adiposity) plays a major role in determining this relationship, with macronutrient composition potentially playing a contributing effect.

The findings of this paper are potentially interesting but it is very difficult to understand the assumptions and mathematical modelling supporting the data. Johansson et al. (2020) framework (ref.12) for measuring life expectancy from disease onset for specific conditions is not very clear, and less so the use of "changes in single dietary components" to determine life expectancy gains in this paper. The authors must make a much better job in explaining how they have calculated life expectancy gain for each single food (or combinations of foods) based on data from meta-analyses (providing dose-response data on the impact of various food groups on mortality). Again, there are a lot of assumptions based on results from meta-analysis data from epidemiological studies that by definition cannot demonstrate causality but just associations. Even more problematic are the assumptions and estimates of life expectancy gain based on duration of change. The time perspective of diet change adds another layer of uncertainty.

The authors stated that the background data have been adjusted for factors such as smoking, exercise, age, and sex. Did they adjusted for BMI, or most importantly weight gain since early adulthood.

*** Reviewer #3:

Alex McConnachie, Statistical Review

The paper by Fadnes et al looks at modelling the possible impact of sustained dietary changes from a western-style diet towards a more optimal diet, on life expectancy. This review considers the statistical elements of the paper.

On the one hand, this could be a very short review, since there are no statistical methods used in the paper, in the usual sense of hypothesis testing and statistical model fitting. Nevertheless, I read the paper with interest, and I have a few comments that I hope will improve the paper.

The descriptions of a typical western diet, the optimal diet, and the feasibility-approach diet were nice and clear. The idea of the FA diet lying half-way between the typical and OD was a good one, as an attempt to reflect what might be practically achievable by most people, though I thought some of the calculations looked wrong. For example, if the typical intake of nuts is taken as zero, and is 25g for the OD, should it be 12.5g (not 25g) for FA? For fish, should it be 125g (not 100g) for fish (midway between 50 and 200g)? The values for the FA diet do not seem to match the way it was described.

The simulation approach looks OK, but was only repeated 200 times for each scenario. Is this enough? Whenever I use a sampling-based method, I tend to use thousands of replications - nowadays, computing power is not an issue with these things, so I think it is worth erring on the high side.

The tables and figures were a little confusing. Looking at Table 1, at the estimates for a 20-year-old, and at Figure 1, I would expect the estimates and uncertainty intervals to be the same - as far as I can tell, they are presenting the same data. But they are not - e.g. for female, for a change in legumes from 0 to 200, the table gives values of 2.0 (1.0, 3.2), but the figure reports 2.00 (0.90, 3.10). Most of the values that I checked differ slightly between the table and the figure. Also, in the combined document I was given to review, there is another version of Figure 1 with different estimates and intervals from both table 2 and the first version of figure 1. These inconsistencies are worrying.

In fact, since the figure shows the same data as the table (or should, as far as I can tell) I would suggest the table is redundant - the figure is more visually appealing, and includes the actual estimates, so is preferable. The tabular format may be better for the supplement, in order to pack in more information per page, but that doesn't really matter.

Another comment on the values reported in the figures - why do all the estimates have zero in the second decimal place? This is too unlikely to be plausible.

In the figures, the uncertainty intervals should not be referred to as "CI" - they are not confidence intervals. "UI" would be more appropriate. Also, is "Effect" the right word for the estimated life years gained?

In terms of layout, the figures have the TW->FA and TW->OD estimates for each food group together. This is fine, but visually, it would help if each pair of estimates were separated slightly. Alternatively, you could put all the TW->FA estimates together, followed by all the TW->OD estimates, with a gap between the two sections. I guess there are lots of ways these figures could be modified, and finding the optimal layout is not easy.

Figure 2 in the paper looks great, except for the fact that it is very hard to tell some of the colours apart. I don't know what could be done about this.

***

Any attachments provided with reviews can be seen via the following link:

[LINK]

Decision Letter 2

Richard Turner

5 Dec 2021

Dear Dr. Fadnes,

Thank you very much for re-submitting your manuscript "Estimating impact of food choices on life expectancy: A modeling study" (PMEDICINE-D-21-04011R2) for consideration at PLOS Medicine.

I have discussed the paper with editorial colleagues and it was also seen again by three reviewers. I am pleased to tell you that, provided the remaining editorial and production issues are fully dealt with, we expect to be able to accept the paper for publication in the journal.

The remaining issues that need to be addressed are listed at the end of this email. Any accompanying reviewer attachments can be seen via the link below. Please take these into account before resubmitting your manuscript:

[LINK]

***Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.***

In revising the manuscript for further consideration here, please ensure you address the specific points made by each reviewer and the editors. In your rebuttal letter you should indicate your response to the reviewers' and editors' comments and the changes you have made in the manuscript. Please submit a clean version of the paper as the main article file. A version with changes marked must also be uploaded as a marked up manuscript file.

Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. If you haven't already, we ask that you provide a short, non-technical Author Summary of your research to make findings accessible to a wide audience that includes both scientists and non-scientists. The Author Summary should immediately follow the Abstract in your revised manuscript. This text is subject to editorial change and should be distinct from the scientific abstract.

We hope to receive your revised manuscript within 1 week. Please email us (plosmedicine@plos.org) if you have any questions or concerns.

We ask every co-author listed on the manuscript to fill in a contributing author statement. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT.

Please ensure that the paper adheres to the PLOS Data Availability Policy (see http://journals.plos.org/plosmedicine/s/data-availability), which requires that all data underlying the study's findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by "data not shown" or "unpublished results." For such statements, authors must provide supporting data or cite public sources that include it.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

Please note, when your manuscript is accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosmedicine@plos.org.

Please let me know if you have any questions, and we look forward to receiving the revised manuscript.   

Sincerely,

Richard Turner, PhD

Senior Editor, PLOS Medicine

rturner@plos.org

------------------------------------------------------------

Requests from Editors:

At the start of the abstract, please consider adapting the text to "Interpreting and utilising the findings of nutritional research can be challenging ...", or similar.

Early in the abstract, please adapt the tense to "... we used life-table methodology ...".

In the abstract, please specify the nature of the uncertainty interval quoted at first use, e.g., "... the United States (10.7 [95% Uncertainty Interval 5.9-14.1] years) ...".

Generally, square brackets should be used within parentheses throughout.

In the abstract and throughout the text, please use the format "age 20 years ...".

In the abstract, please add spaces to "... females: 2.0 ..." and similar.

In the abstract, should that be "... 20-year old women"?

Please adapt the current final sentence of the "Methods and findings" subsection of the abstract to "Using NutriGrade the overall quality of evidence was assessed as moderate.", or similar, and move this before the final sentence of the subsection.

Please trim the discussion of limitations in the abstract to one sentence to conclude the "Methods and findings" subsection.

In the author summary, under the subsection "What did the researchers do and find?" please either add a new initial point to briefly describe the approach used or, alternatively, the existing first point could be adapted to do this.

In the Methods section (main text), please state when the Pubmed search was done.

Noting the long paragraph on limitations in the discussion, please break this up into at least two paragraphs.

Please remove footnotes (this information can be integrated into the text).

Please use an initial capital for "Western" (diet) consistently, throughout.

Throughout the text, please remove spaces from the reference call-outs, e.g., "... data sources [28,29]." in the Discussion.

In the reference list, please abbreviate journal names consistently (noting reference 31 and others).

Please spell out the institutional author names for references 1 & 17.

For reference 3 and any other relevant references, please adapt the journal name abbreviation to "BMJ".

Please remove "[cited 2020]" from reference 12.

Please use the journal name abbreviation "PLoS ONE" for reference 13.

Comments from Reviewers:

*** Reviewer #1:

Thank you for taking on board the various reviewers' suggestions, which were all intended to be constructive.

I think you have now made your good paper even better.

*** Reviewer #2:

The authors have constructively responded and addressed my concerns.

*** Reviewer #3:

Alex McConnachie, Statistical Review

I thank the authors for their responses, all of which are satisfactory. I have no further comments.

Regarding the figures, I find R is highly flexible.

***

Any attachments provided with reviews can be seen via the following link:

[LINK]

Decision Letter 3

Richard Turner

11 Dec 2021

Dear Dr Fadnes, 

On behalf of my colleagues and the Academic Editor, Dr Fontana, I am pleased to inform you that we have agreed to publish your manuscript "Estimating impact of food choices on life expectancy: A modeling study" (PMEDICINE-D-21-04011R3) in PLOS Medicine.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Once you have received these formatting requests, please note that your manuscript will not be scheduled for publication until you have made the required changes.

Prior to final acceptance, please address some minor points:

The correct name of the GBD study is used, but we suggest writing "Global Burden of Disease" (rather than "Diseases") where the short name is used, e.g. early in the abstract.

At first mention of "Food4HealthyLife" in the abstract, please amend the text to "... calculator that we provide online could be useful ..." or similar.

Where "TRIPOD" is referred to late in the Methods section, please remove "tried to" (e.g., "We adhered to the ...").

Please add "95%" to "Uncertainty Interval", if appropriate.

Early in the Results section (main text) please add "Uncertainty Interval" to the first such quoted.

In the meantime, please log into Editorial Manager at http://www.editorialmanager.com/pmedicine/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process. 

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with medicinepress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Thank you again for submitting to PLOS Medicine. We look forward to publishing your paper. 

Sincerely, 

Richard Turner, PhD 

Senior Editor, PLOS Medicine

rturner@plos.org

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Medline/PubMed search to estimate number of nutritional articles per year.

    (PDF)

    S2 Text. String used in PubMed to identify meta-analyses for setting hazard ratios.

    (PDF)

    S3 Text. Estimated intake of various food groups in the United States and Norway.

    (PDF)

    S1 Table. Hazard ratios (with uncertainty intervals) for various food groups with uncertainty limits (orange/red labels).

    (PDF)

    S2 Table. Increase in LE for each food group change for 20- and 60-year-old female and male adults from the United States, who change from a TW to OD or FA.

    FA, feasibility approach diet; LE, life expectancy; OD, optimized diet; TW, typical Western diet.

    (PDF)

    S3 Table. Absolute and relative change in LE with delay to full effects of 10 (default), 5, 30, and 50 years for 20-, 40-, 60-, and 80-year-old females and males from the United States.

    LE, life expectancy.

    (PDF)

    S1 Fig. Example of calculator input and output.

    (PDF)

    S2 Fig. Expected life years gained for 20-year-old female adults from China who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams.

    (PNG)

    S3 Fig. Expected life years gained for 20-year-old male adults from China who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S4 Fig. Expected life years gained for 20-year-old female adults from Europe who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S5 Fig. Expected life years gained for 20-year-old male adults from Europe who change from a typical Western diet to an optimized or feasible approach diet with changes indicated in grams.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S6 Fig. Expected life years gained for 20-year-old female adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S7 Fig. Expected life years gained for 20-year-old male adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S8 Fig. Expected life years gained for 40-year-old female adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S9 Fig. Expected life years gained for 40-year-old male adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S10 Fig. Expected life years gained for 60-year-old female adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S11 Fig. Expected life years gained for 60-year-old male adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S12 Fig. Expected life years gained for 80-year-old female adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S13 Fig. Expected life years gained for 80-year-old male adults from the United States who change from a typical Western diet to an optimized or feasible approach diet.

    Estimates per food group and change in LE are presented with 95% UIs. LE, life expectancy; 95% UI, 95% uncertainty interval.

    (PNG)

    S14 Fig. Expected life years gained for 20-, 40-, 60-, and 80-year-old male and female adults from the US, China, and EU, who change from a typical Western diet to an optimized* (labeled “Optimal”) or a feasibility approach diet* (labeled “Feasible”).

    Estimates for change in LE is presented with 95% UIs. *For the optimal diet and feasibility approach diet, the following intakes were used: 225/137.5 g whole grains (fresh weight), 400/325 g vegetables, 400/300 g fruits, 25/12.5 g nuts, 200/100 g legumes, 200/125 g fish, 25/37.5 g eggs, 200/250 g milk/dairy, 50/100 g refined grains, 0/50 g red meat, 0/25 g processed meat, 50/62.5 g white meat, 0/250 g sugar-sweetened beverages, and 25/25 g added plant oils. **F20 indicates 20-year-old females, and M60 indicates 60-year-old males. Uncertainty intervals for some food groups have rounding differences compared to corresponding S2 Table due to symmetrical adjustment in the admetan package in Stata. EU, Europe; LE, life expectancy; US, United States; 95% UI, 95% uncertainty interval.

    (PNG)

    S15 Fig. Expected life years gained for 20-, 40-, 60-, and 80-year-old male and female adults from the US, China, and EU, who change from a typical Western diet to an optimized* (labeled “Optimal”) or a feasibility approach diet* (labeled “Feasible”).

    Estimates for change in LE is presented with sensitivity adjusted uncertainty intervals using lower interval as model adjustment of 0.5 and upper interval as model adjustment of 1.5. *For the optimal diet and feasibility approach diet, the following intakes were used: 225/137.5 g whole grains (fresh weight), 400/325 g vegetables, 400/300 g fruits, 25/12.5 g nuts, 200/100 g legumes, 200/125 g fish, 25/37.5 g eggs, 200/250 g milk/dairy, 50/100 g refined grains, 0/50 g red meat, 0/25 g processed meat, 50/62.5 g white meat, 0/250 g sugar-sweetened beverages, and 25/25 g added plant oils. **F20 indicates 20-year-old females, and M60 indicates 60-year-old males. Uncertainty intervals for some food groups have rounding differences compared to corresponding S2 Table due to symmetrical adjustment in the admetan package in Stata. EU, Europe; LE, life expectancy; US, United States.

    (PNG)

    S16 Fig. Expected increase in LE for optimizing different food groups with diet changes initiating from various ages between 20 and 80 years of age (time to full effect: 5 years).

    *For the optimal diet and feasibility approach diet, the following intakes were used: 225 g and 137.5 g whole grains (fresh weight), 400 g and 325 g vegetables, 400 g and/ 300 g fruits, 25 g and 12.5 g nuts, 200 g and/ 100 g legumes, 200 g and 100 g fish, 25 g and 37.5 g eggs, 200 g and 250 g milk/dairy, 50 g and 100 g refined grains, 0 g and 50 g red meat, 0 g and 25 g processed meat, 50 g and 62.5 g white meat, 0 g and 250 g sugar-sweetened beverages, and 25 g and 25 g added plant oils. LE, life expectancy.

    (PDF)

    S17 Fig. Expected increase in LE for optimizing different food groups with diet changes initiating from various ages between 20 and 80 years of age (time to full effect: 30 years).

    *For the optimal diet and feasibility approach diet, the following intakes were used: 225 g and 137.5 g whole grains (fresh weight), 400 g and 325 g vegetables, 400 g and/ 300 g fruits, 25 g and 12.5 g nuts, 200 g and/ 100 g legumes, 200 g and 100 g fish, 25 g and 37.5 g eggs, 200 g and 250 g milk/dairy, 50 g and 100 g refined grains, 0 g and 50 g red meat, 0 g and 25 g processed meat, 50 g and 62.5 g white meat, 0 g and 250 g sugar-sweetened beverages, and 25 g and 25 g added plant oils. LE, life expectancy.

    (PDF)

    S1 TRIPOD Checklist. Checklist for prediction model development.

    (PDF)

    Attachment

    Submitted filename: Response-reviewer-3-R1-F4HL-PLOS Medicine.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLoS Medicine are provided here courtesy of PLOS

    RESOURCES